Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04049695 · ClinicalTrials.gov registry record · NA

Improving Cognition After Cancer

A NA study of Cognitive Dysfunction and Breast Cancer Survivors, sponsored by University of California, San Diego.

Active
Registry status
NA
Development phase
253
Enrollment target
1
Study location

NCT04049695 is a NA study of Cognitive Dysfunction and Breast Cancer Survivors that is active but no longer recruiting, run by University of California, San Diego. The registered enrollment target is 253 participants, below the 1,987-participant average among 45 other Cognitive Dysfunction trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04049695, a NA study of Cognitive Dysfunction and Breast Cancer Survivors, is active but no longer recruiting, sponsored by University of California, San Diego.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
253 participants
Enrollment target
1
Study location

Study Summary

This study will test whether a physical activity intervention can improve cognition in breast cancer survivors and help the development of physical activity guidelines for cognition in breast cancer survivors.

Interventions

  • BEHAVIORAL Exercise
  • BEHAVIORAL Control

Study Locations (1)

California

  • Moores UCSD Cancer Center - La Jolla

Trial Details

FieldValue
Enrollment Target 253 participants
Start Date 2019-09-09
Est. Completion 2025-02-01
Phase NA

Sponsor

University of California, San Diego

775 total trials

What the Registry Record Tells You About NCT04049695

The ClinicalTrials.gov registry entry for NCT04049695 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 253 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,987-participant average among 45 other Cognitive Dysfunction trials with a reported enrollment target (87% lower). The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Cognitive Dysfunction appearing as the primary indexed condition, and to 2 interventions - of which Exercise is the first listed.

NCT04049695 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT04049695 about?

NCT04049695 is a clinical study titled "Improving Cognition After Cancer". This study will test whether a physical activity intervention can improve cognition in breast cancer survivors and help the development of physical activity guidelines for cognition in breast cancer survivors.

What is the current status of trial NCT04049695?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 253 participants. The study started on 2019-09-09. Estimated completion is 2025-02-01.

What conditions does trial NCT04049695 study?

This clinical trial studies the following conditions: Cognitive Dysfunction, Breast Cancer Survivors.

What interventions are being tested in trial NCT04049695?

The interventions under investigation include: Exercise (BEHAVIORAL), Control (BEHAVIORAL).

Who is sponsoring clinical trial NCT04049695?

This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04049695 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cognitive Dysfunction

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.